Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women. [electronic resource]
- Medical science monitor : international medical journal of experimental and clinical research Jan 2019
- 259-268 p. digital
Publication Type: Journal Article
1643-3750
10.12659/MSM.913752 doi
Aged Alendronate--therapeutic use Alkaline Phosphatase--blood Biomarkers--blood Bone Density--drug effects Bone Resorption--drug therapy China Female Humans Mesenchymal Stem Cells--drug effects Middle Aged Osteocalcin--blood Osteogenesis--drug effects Osteoporosis, Postmenopausal--drug therapy Parathyroid Hormone--administration & dosage Postmenopause Teriparatide--pharmacology